Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 77
Filter
Add more filters











Publication year range
1.
Sci Rep ; 8(1): 3031, 2018 02 14.
Article in English | MEDLINE | ID: mdl-29445205

ABSTRACT

Saliva collection is considered a non-invasive method to detect inflammatory markers in response to emotional states within natural social contexts. Numerous studies have prompted an important role of cytokines in modulating distinct aspects of social and emotional behavior. The aim of this study was to investigate the reliability of plasma and saliva as investigative tools for measure some inflammatory marker levels (CRP, IL-1ß, IL-18, and IL-6). At the same time, the relationships between these markers and emotional states in response to a socio-cognitive stress (Academic Exam, AE), were considered. It was demonstrated that the plasma and saliva concentrations of all immune-mediators analyzed were significantly related across the socio-cognitive stress. In addition, when there was a close correlation to AE, the anger state, the IL-1ß, the IL-18 salivary and plasmatic concentrations were significantly higher, while they decreased during the AE. On the other hand, the anxiety state and the IL-6 levels significantly increased throughout the AE. The IL-1ß and IL-6 were positively associated to the anger and the anxiety state, respectively. In conclusion, our data highlight that different immune markers are similarly detectable in plasma and saliva during socio-cognitive stress. Also, they could be related to different emotional responses.


Subject(s)
Emotions/physiology , Interleukins/blood , Interleukins/metabolism , Saliva/metabolism , Adult , Biomarkers/analysis , C-Reactive Protein/metabolism , Cytokines/blood , Humans , Interleukin-18/blood , Interleukin-18/metabolism , Interleukin-1beta/blood , Interleukin-1beta/metabolism , Interleukin-6/blood , Interleukin-6/metabolism , Male , Reproducibility of Results , Stress, Psychological/blood , Stress, Psychological/metabolism , Stress, Psychological/psychology , Young Adult
2.
Cell Prolif ; 51(2): e12432, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29357406

ABSTRACT

OBJECTIVES: In our previous reports, we have demonstrated that extremely low-frequency electromagnetic fields (ELF-EMF) exposure enhances the proliferation of keratinocyte. The present study aimed to clarify effects of ELF-EMF on wound healing and molecular mechanisms involved, using a scratch in vitro model. MATERIALS AND METHODS: The wounded monolayer cultures of human immortalized keratinocytes (HaCaT), at different ELF-EMF and Sham exposure times were monitored under an inverted microscope. The production and expression of IL-1ß, TNF-α, IL-18 and IL-18BP were measured by enzyme-linked immunosorbent assay and quantitative real-time PCR. The activity and the expression of matrix metalloproteinases (MMP)-2/9 was evaluated by zymography and Western blot analysis, respectively. Signal transduction proteins expression (Akt and ERK) was measured by Western blot. RESULTS: The results of wound healing in vitro assay revealed a significant reduction of cell-free area time-dependent in ELF-EMF-exposed cells compared to Sham condition. Gene expression and release of cytokines analysed were significantly increased in ELF-EMF-exposed cells. Our results further showed that ELF-EMF exposure induced the activity and expressions of MMP-9. Molecular data showed that effects of ELF-EMF might be mediated via Akt and ERK signal pathway, as demonstrated using their specific inhibitors. CONCLUSIONS: Our results highlight ability of ELF-EMF to modulate inflammation mediators and keratinocyte proliferation/migration, playing an important role in wound repair. The ELF-EMF accelerates wound healing modulating expression of the MMP-9 via Akt/ERK pathway.


Subject(s)
Cytokines/metabolism , Electromagnetic Fields , Keratinocytes/metabolism , MAP Kinase Signaling System , Matrix Metalloproteinase 9/metabolism , Wound Healing , Cell Line, Transformed , Humans , Inflammation/metabolism , Inflammation/pathology , Inflammation/therapy , Keratinocytes/pathology
3.
Neurosci Res ; 106: 23-8, 2016 May.
Article in English | MEDLINE | ID: mdl-26646400

ABSTRACT

Executive Functions (EFs) involve a set of high cognitive abilities impairment which have been successfully related to a redox omeostasis imbalance in several psychiatric disorders. Firstly, we aimed to investigate the relationship between executive functioning and some oxidative metabolism parameters in Peripheral Blood Mononuclear Cells (PBMCs) from healthy adult samples. The Brown Attention-Deficit Disorder Scales were administered to assess five specific facets of executive functioning. Total superoxide anion production, Super Oxide Dismutase (SOD), Catalase (CAT), Glutathione Reductase (GR) and Glutathione Peroxidase (GPx) activities were evaluated on proteins extracted from the PBMCs. We found significant positive correlations between superoxide anion production and the total score of the 'Brown' Scale and some of its clusters. The GPx and CAT activities were negatively associated with the total score and some clusters. In a linear regression analysis, these biological variables were indicated as the most salient predictors of the total score, explaining the 24% variance (adjusted R(2)=0.24, ANOVA, p<.001). This study provides novel evidence that Executive Functions have underpinnings in the oxidative metabolism, as ascertained in healthy subjects.


Subject(s)
Antioxidants/metabolism , Executive Function , Leukocytes, Mononuclear/metabolism , Superoxides/metabolism , Adult , Catalase/blood , Female , Glutathione Peroxidase/blood , Glutathione Reductase/blood , Humans , Leukocytes, Mononuclear/enzymology , Male , Superoxide Dismutase/blood , Young Adult
4.
Brain Behav Immun ; 41: 251-60, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24793756

ABSTRACT

BACKGROUND: Recent lines of research have boosted awareness of the immunological facets of schizophrenia. However, associations with protein tyrosine phosphatase regulators have never been reported. The aim of our study was to investigate the expression and promoter status methylation of phosphatase SHP-1, a key negative regulator of the inflammatory process, in Peripheral blood mononuclear cells (PBMCs) of Schizophrenic patients. METHODS: We enrolled fifty-four (28 men and 26 women) unmedicated first episode subjects (SC) who met DSM-IV and thirty-eight (22 men and 16 women) healthy controls (HC). The SC psychopathological status was assessed using the Positive and Negative Syndrome Scale. We evaluated SHP-1 expression by Quantitative Real-time PCR (qPCR) and Western blotting (WB) methods and promoter status methylation through PCR bisulfate. IKK/NFkB signaling was detected by WB, and medium and plasma levels of pro-inflammatory cytokines (IL-1ß, IL-2, and TNF-α) by the ELISA method. SHP-1 was silenced by treating cells with specific siRNA. RESULTS: We found a significantly lower level of SHP-1 gene expression in PBMCs from SC vs. HC, consistently with which the promoter region analyzed presented significant hypermethylation. Silencing of SHP-1 expression induced higher activation of IKK/NF-kB signaling and pro-inflammatory cytokine production in ex vivo PBMCs from both SC and HC. Linear regression among patients generated a model in which SHP-1 expression explained 30% of the clinical negative symptom variance (adjusted R(2)=0.30, ANOVA p<0.001). CONCLUSIONS: Our findings are the first to suggest that impairment of SHP-1 expression is involved in the physiopathology of schizophrenia, opening fruitful new avenues for ameliorating treatment at least of negative symptoms.


Subject(s)
Cytokines/biosynthesis , Protein Tyrosine Phosphatase, Non-Receptor Type 6/physiology , Schizophrenia/enzymology , Adult , C-Reactive Protein/analysis , Cytokines/genetics , DNA Methylation , Female , Humans , I-kappa B Kinase/metabolism , Leukocytes, Mononuclear/enzymology , Male , Middle Aged , NF-kappa B/metabolism , Promoter Regions, Genetic , Protein Tyrosine Phosphatase, Non-Receptor Type 6/antagonists & inhibitors , Protein Tyrosine Phosphatase, Non-Receptor Type 6/biosynthesis , Protein Tyrosine Phosphatase, Non-Receptor Type 6/genetics , RNA Interference , RNA, Messenger/biosynthesis , RNA, Small Interfering/pharmacology , Schizophrenia/genetics , Schizophrenia/immunology , Schizophrenia/physiopathology , Schizophrenic Psychology , Severity of Illness Index
5.
J Biol Regul Homeost Agents ; 27(3): 739-48, 2013.
Article in English | MEDLINE | ID: mdl-24152841

ABSTRACT

Heart failure (HF) is a common clinical syndrome with frequent exacerbations requiring hospitalization. Among the various mechanisms that underlie the pathogenesis of HF, the activation of the immune system leads to a progressive and redundant release of proinflammatory cytokines responsible for a variety of deleterious effects in heart failure, such as endothelial dysfunction, apoptosis of myocytes, activation of MMPs (Matrix Metallo Proteinases) and oxidative stress, with the result of decreased inotropism and clinical syndrome such as pulmonary edema,. The condition of oxidative stress induces the expression of genes coding for the proteins inducible nitric oxide synthase (iNOS) and heme oxygenase-1 (HO-1). Twenty-five hospitalized cardiology patients with symptomatic acute congestive HF (NYHA Class III-IV) and impaired left ventricular (LV) function (ejection fraction less than 35 percent) were included in the study. The aim of this study was to evaluate the cytokines plasma concentrations and the expression and activity of iNOS and HO-1 proteins in peripheral blood mononuclear cell (PBMC) extracted from patients in comparison to control group. In ACHF; left ventricular ejection fraction (LVEF) percent was reduced. Furthermore; iNOS and HO-1 expression and cytokines plasma levels were significantly higher in patients with ACHF as compared to controls group. Moreover the enzyme activity presents an opposite trend compared to that obtained in the analysis of the transcript and proteins. Our studies suggest a negative feedback interaction between iNOS and HO-1 important in the physiopathology of heart failure that could be considered a good candidate as a future therapeutic target for the development of new drugs.


Subject(s)
Heart Failure/physiopathology , Heme Oxygenase-1/physiology , Leukocytes, Mononuclear/metabolism , Nitric Oxide Synthase Type II/physiology , Acute Disease , Aged , Feedback, Physiological , Female , Humans , Male , Middle Aged , NF-kappa B/metabolism , Ventricular Function, Left
6.
J Biol Regul Homeost Agents ; 27(4): 1069-75, 2013.
Article in English | MEDLINE | ID: mdl-24382189

ABSTRACT

The roles of nitric oxide (NO) synthase (NOS) enzyme in pathological mechanisms of the oral cavity are still incompletely understood. The aim of this study was to investigate the expression of the endothelial, neuronal and inducible isoforms of NOS (eNOS, nNOS and iNOS) in oral lichen planus (OLP) development in humans. OLP and healthy oral mucosa biopsies were taken for mRNA and protein analysis of NOS isoenzymes by RT-PCR, western blot and immunohistochemistry. The mRNA and protein levels of eNOS and nNOS were present in all samples, with a significant increase only for eNOS in OLP. The normal oral mucosa exhibited only small amounts of iNOS mRNA and protein, while it showed a significant rise in OLP samples. These results were confirmed by immunohistochemical analysis. Our findings suggest that NO produced by increased eNOS and iNOS expression may have circulatory and immune functions in the development of OLP.


Subject(s)
Lichen Planus, Oral/enzymology , Nitric Oxide Synthase/analysis , Adult , Blotting, Western , Female , Humans , Immunohistochemistry , Isoenzymes/analysis , Isoenzymes/genetics , Male , Middle Aged , Nitric Oxide/biosynthesis , Nitric Oxide Synthase/genetics
7.
J Biol Regul Homeost Agents ; 25(3): 323-9, 2011.
Article in English | MEDLINE | ID: mdl-22023756

ABSTRACT

During the past decade, a great deal of data has accumulated supporting the notion that cytokines interact to regulate several aspects of social and emotional behaviour. There are reports of a positive correlation between cytokine levels and aggressive behaviour in healthy populations, and clinical reports describe an increase of aggressive traits in patients who receive cytokine immunotherapy. Interleukin-1beta released during an immune response acts as messenger that helps to modulate behaviour by influencing relevant neurotransmitter systems, and in some cases, by directly acting within the brain. In this site, IL-1beta exerts its actions by acting through 5-HT2 and IL-1 Type I receptors in hypothalamus or by potentially indirect routes, including activation of sensory afferents, and stimulation of cytokine release by brain endothelial cells. This review reports research investigating the relationship between IL-1beta, and the immune and central nervous systems involving or potentially involving defensive aggressive behaviour.


Subject(s)
Aggression , Defense Mechanisms , Hypothalamus/immunology , Interleukin-1beta/immunology , Receptors, Interleukin-1 Type I/immunology , Serotonin/immunology , Synaptic Transmission/immunology , Humans , Hypothalamus/metabolism , Interleukin-1beta/metabolism , Receptors, Interleukin-1 Type I/metabolism , Serotonin/metabolism
8.
Int J Immunopathol Pharmacol ; 24(2): 305-11, 2011.
Article in English | MEDLINE | ID: mdl-21658305

ABSTRACT

This review examines recent articles on the relationship of cytokines to allergy and inflammation with particular emphasis on interleukin (IL)-4. The objective of this article is therefore to review published studies to identify cytokines consistently involved in allergic inflammation. Proinflammatory cytokines, including IL-4, IL-5, IL-13 and GM-CSF along with TNF-alpha play a role in allergen-induced airway leukocyte recruitment and these cytokines can be generated by T mast cells and other cells. In addition, IL-9, IL-25, IL-33, IL-17, IL-27 and IFN-gamma are deeply involved in the regulation of asthma. Blocking the effect of these proinflammatory cytokines might provide new therapeutic approaches for the control of allergy and inflammation.


Subject(s)
Cytokines/metabolism , Hypersensitivity/immunology , Inflammation Mediators/metabolism , Inflammation/immunology , Interleukin-4/metabolism , Animals , Humans , Signal Transduction
9.
Int J Immunopathol Pharmacol ; 23(3): 709-13, 2010.
Article in English | MEDLINE | ID: mdl-20943040

ABSTRACT

Cytokines are immunal regulatory proteins, however they also play a relevant role in inflammatory diseases. IL-31 is a newly discovered cytokine expressed primarily in TH2 cells, introduced by activated CD4+ T cells. IL-31 is capable of inducing chemokines and other cytokines in several inflammatory diseases via its surface receptor. This cytokine is also produced by mast cells and mast cell line, suggesting a role in allergic diseases. In this editorial we revisit the biological role of IL-31 in immunity and inflammation.


Subject(s)
Cytokines/physiology , Immunity/physiology , Inflammation/physiopathology , Interleukins/immunology , Interleukins/physiology , Th2 Cells/physiology , Chemokines/biosynthesis , Humans , Hypersensitivity/immunology , Mast Cells/metabolism
10.
J Biol Regul Homeost Agents ; 24(3): 229-37, 2010.
Article in English | MEDLINE | ID: mdl-20846471

ABSTRACT

Mast cells play an essential role in diverse physiological and pathological processes, such as atherosclerosis, malignancy, asthma, pulmonary fibrosis and arthritis, directly interact with bacteria, and appear to play a vital role in host defense against pathogens. Mast cells could be recruited in the inflammatory site, by MCP-1, RANTES and SCF, to selectively secrete proinflammatory molecules; these could include growth factors, histamine, which is mitogenic (H1) and an immunosuppressant (H2), neovascularization agents, such as heparin, IL-8, and VEGF, as well as proteases that could permit new blood vessel formation. Neurogenic inflammation involves vasodilation and plasma protein extravasation in response to neural stimulation. Upon stimulation, sensory neurons release Substance P and other neuropeptides and activate neurokinin-1 receptors leading to plasma protein extravasation from post-capillary venules. Substance P is a neuropeptide that is released from nerve endings in many tissues and plays an important role in immunological and inflammatory states, and it is also a mediator of tissue injury, asthma, arthritis, allergy and autoimmune diseases. SP-positive nerve fibers and mast cell contacts are increased by acute stress in mice leading to dermal mast cell degranulation. VEGF is produced by flammatory cells. IL-33 is the newest inflammatory member of the IL-1 cytokine family and we show here that SP can induce VEGF secretion from mast cells and IL-33 augments the effect of SP in VEGF transcription and translation protein.


Subject(s)
Mast Cells/physiology , Stress, Psychological/immunology , Substance P/physiology , Vascular Endothelial Growth Factor A/physiology , Animals , Cytokines/biosynthesis , Humans , Stress, Psychological/metabolism
11.
J Biol Regul Homeost Agents ; 24(1): 1-6, 2010.
Article in English | MEDLINE | ID: mdl-20385066

ABSTRACT

Chemokines are cytokines with chemotactic properties on inflammatory cells and other cell types. RANTES, MCP-1 and related molecules, constitute the C-C class of chemokine supergene family and a group of cytokines produced by hematopoietic cells, while IL-8 constitute the C-X-C class. The roles of most of these chemokines are not well known, although members of the chemokine family are inflammatory agents. The C-C chemokine plays a role in regulating Th-cell cytokine production and leukocyte trafficking. In this study we clearly show that RANTES and MCP-1 are mediators of acute inflammatory responses. Our report describes additional biological activities for RANTES, MCP-1, and IL-8, suggesting that these chemokines play a fundamental role in histamine and serotonin generation and cell function in mast cells.


Subject(s)
Chemokine CCL2/physiology , Chemokine CCL5/physiology , Interleukin-8/physiology , Mast Cells/physiology , Animals , Histamine Release/physiology , Humans , Inflammation/etiology , Inflammation/physiopathology , Inflammation Mediators/physiology , Serotonin/physiology , Signal Transduction
12.
Int J Immunopathol Pharmacol ; 23(4): 991-6, 2010.
Article in English | MEDLINE | ID: mdl-21244748

ABSTRACT

The immune system is a highly complex, intricately regulated group of cells whose integrated function is essential to health. The mast cell inflammatory response is characterized by an early phase with massive discharge of mediators stored in cytoplasmic secretory granules. Through multigranular/compound exocytosis and a late phase that involves generation of arachidonic acid metabolites and de novo synthesis of cytokines/chemokines and growth factors. Vitamins have been shown to have a protective effect on the body's immune cells. Vitamin C and E are necessary in allergic disease treatment where mast cells are involved. In addition, ascorbic acid and pyridoxine are useful compounds for the treatment of inflammatory disorder of the respiratory airways. Here we revisited the inter-relationship between vitamins and mast cells.


Subject(s)
Immune System/drug effects , Mast Cells/drug effects , Vitamins/pharmacology , Animals , Humans , Mast Cells/physiology , Vitamin B 6/pharmacology , Vitamin D/pharmacology , Vitamin E/pharmacology
13.
J Biol Regul Homeost Agents ; 23(4): 231-8, 2009.
Article in English | MEDLINE | ID: mdl-20003762

ABSTRACT

Mast cells play a role in various physiological functions: innate and acquired immunity, epithelium remodelling and proliferation, angiogenesis, cancer, inflammation and infections. Mast cells are activated by cross-linking of FcERI molecules, which are involved in the binding of multivalent antigens to the attached IgE molecules, resulting in a variety of responses including the immediate release of potent inflammatory mediators. In addition, mast cell biology consists in the capability to secrete preformed mediators which include biogenic amines and newly synthetized mediators, which include lipid-derived mediators and cytokines. It has been reported that parasite infections induce a systemic immunomodulatory network, including regulatory T cells, pro-inflammatory and anti-inflammatory cytokines, which might play a key role in the allergic phenotype. Here, in this article, we revisited the relationship between mast cells and infections.


Subject(s)
Immunoglobulin E/immunology , Infections/immunology , Inflammation Mediators/immunology , Mast Cells/immunology , Receptors, IgE/immunology , Animals , Humans , Immunoglobulin E/metabolism , Infections/metabolism , Infections/parasitology , Inflammation Mediators/metabolism , Mast Cells/metabolism , Receptors, IgE/metabolism
14.
J Biol Regul Homeost Agents ; 23(3): 141-7, 2009.
Article in English | MEDLINE | ID: mdl-19828090

ABSTRACT

IL-32, a newly-discovered proinflammatory cytokine that activates the p38MAPK and NF-kappaB pathways, is an important player in innate and adaptive immune response. IL-32, a cytokine produced mainly by T, natural killer, and epithelial cells induces significant amounts of TNFalpha and MIP-2 and increases the production of both cytokines in a dose-dependent manner. IL-32 has been implicated in inflammatory disorders, mycobacterium tuberculosis infections, inflammatory bowel disease, and influenza A virus infection, as well as in some autoimmune diseases, such as rheumatoid arthritis, ulcerative colitis and Crohn?s disease and in human stomach cancer, human lung cancer and breast cancer tissues. Moreover, it has been reported that IL-32 has pro-inflammatory effects on myeloid cells and causes the differentiation of osteoclast precursors into multinucleated cells expressing specific osteoclast markers. We recently found that human IL-32 has the capacity to provoke histamine release in human-derived cord blood mast cells (HDCBMC), but not in LAD 2 cells nor in rat peritoneal mast cells (RPMC), showing that IL-32 may be specie specific and act more in mature human mast cells (HDCBMC) than in transformed mast cells (LAD 2 cells). Certainly, IL-32 is another potent proinflammatory cytokine, however, the specific role of this newly-discovered protein in the network of cytokine biology remains to be determined.


Subject(s)
Inflammation Mediators/metabolism , Interleukins/metabolism , Animals , Cell Differentiation , Humans , Immunity , NF-kappa B/metabolism
15.
J Biol Regul Homeost Agents ; 23(3): 189-95, 2009.
Article in English | MEDLINE | ID: mdl-19828096

ABSTRACT

Verbascum mallophorum is part of a large family of Scrophulariaceae consisting of more than 360 species. Verbascum mallophorums contains diverse polysaccharides, iroid glycosides, flavonoids, saponins, volatile oils and phenylentanoids. Verbascum has been used in popular medicine for treating wounds, chilblains, respiratory ailments, acne and arthritic disturbances. Inducible nitric oxide synthase (iNOS) represents one of the three isoforms that produce nitric oxide using L-arginine as a substrate in response to an increase in superoxide anion activated by NF-kappaB. It is implicated in different pathophysiological events and its expression increases greatly during an inflammatory process due to oxidative stress. In our study we reproduced an inflammatory state by treating THP-1 cells (human myelomonocytic leukaemia) with pro-inflammatory stimuli, such as LPS and IFN-gamma, obtaining an up-regulation both in the expression and in the activity of iNOS. The aim of our work is to investigate the possible antiinflammatory action of verbascoside extract from Verbascum mallophorum using a concentration of 100 muM. Our results show a significant decrease in the expression and activity of iNOS and extracellular O2- when cells were treated with verbascoside. Based on these results we hypothesize that verbascoside extract from Verbascum mallophorum has anti-inflammatory properties since it reduces the production of superoxide radicals and consequently reduces the activity of iNOS.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Verbascum/chemistry , Blotting, Western , Cell Line , Citrulline/biosynthesis , Densitometry , Gene Expression Regulation, Enzymologic/drug effects , Glucosides/pharmacology , Humans , Interferon-gamma/pharmacology , Lipopolysaccharides/pharmacology , NF-kappa B/metabolism , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Phenols/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Superoxides/metabolism
16.
Neurotox Res ; 15(1): 49-56, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19384587

ABSTRACT

Substance P (SP) is an important neuropeptide involved in neurogenic inflammation and most of its pathophysiological functions are mediated through binding to the neurokinin-1 receptor. SP exerts various proinflammatory actions on immune-cells, including macrophages. Several compounds such as cytokines have the capacity to activate and stimulate macrophages to produce arachidonic acid oxygenation and lipoxygenation products. Leukotriene B4 (LTB4) is one of the most important mediators of leukocyte activation in acute and chronic inflammatory reactions. LTB4 stimulates chemotaxis, lysosomal enzyme release, and cell aggregation. In this report, we studied the effect of SP on rat adherent granuloma macrophages (RAGMs). The chronic granuloma in rat was induced by dorsal injections of a potassium permanganate (KMnO4) saturated crystal solution (200 microl of a 1:40 dilution). After 7 days, all rats developed a subcutaneous granuloma in the injection site from which infiltrated macrophages were extracted, isolated, and cultured in vitro. We tested the hypothesis that SP stimulates the production of LTB4 in RAGMs and increases lipoxygenase expression. Here we show that the cell-free supernatant of RAGMs stimulated with SP (10 microM), resulted in statistically significant increases of LTB4 Preincubation of RAGMs with NDGA (nordihydroguaiaretic acid (10 microM), completely abolished the production of LTB(4) in the supernatants and lipoxygenase expression on RAGMs challenged with SP, or the cation ionophore A23187 (positive control). Similar effects were obtained when the cells were pretreated with dexamethasone (10 microM). Our results suggest that SP is able to stimulate the release of LTB4 and lipoxygenase expression in macrophages from chronic inflammatory granuloma and provide further evidence for a neuroinflammatory pathway.


Subject(s)
Granuloma/pathology , Leukotriene B4/metabolism , Macrophages/drug effects , Macrophages/metabolism , Substance P/pharmacology , Up-Regulation/drug effects , Animals , Arachidonate 5-Lipoxygenase/genetics , Arachidonate 5-Lipoxygenase/metabolism , Calcimycin/pharmacology , Dexamethasone/pharmacology , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Interactions , Granuloma/chemically induced , Ionophores/pharmacology , Leukotriene B4/genetics , Lipoxygenase Inhibitors/pharmacology , Macrophages/ultrastructure , Male , Masoprocol/pharmacology , Microscopy, Electron, Transmission/methods , Potassium Permanganate , Radioimmunoassay/methods , Rats , Rats, Wistar , Time Factors
17.
Int J Immunopathol Pharmacol ; 22(1): 15-9, 2009.
Article in English | MEDLINE | ID: mdl-19309548

ABSTRACT

Autism spectrum disorder is of interest neurochemically because it represents a relatively homogeneous disorder with regard to disease development, abnormal cognitive development and intellectual development disturbance. A consistent finding in autistic children is a high number of mast cells and a high level of serotonin which is also found at elevated concentrations in the urine of autistic patients. In addition, a dysfunction of clinical conditions, such as gastrointestinal and immunological symptoms, is frequently noted in autistic children, however, IgE does not appear to be prevalent in these children but probably an increase of cytokines/chemokines produced by mast cells at an early age may play an important role. Therefore an immune hypothesis, involving also autoimmunity, is one possible pathogenetic mechanism in autism. In conclusion, mast cell activation could contribute to immune and neuroinflammatory abnormalities that are evident in patients with autism spectrum disorders.


Subject(s)
Autistic Disorder/immunology , Immunity , Ammonia/blood , Cytokines/biosynthesis , Humans , Mast Cells/physiology , Serotonin/physiology
18.
Clin Invest Med ; 31(6): E362-72, 2008 Dec 01.
Article in English | MEDLINE | ID: mdl-19032907

ABSTRACT

PURPOSE: Mast cells play an important role in innate and acquired immunity and are thought to be the cellular origin of most proteases and cytokines. Substance P (SP) and its receptor, NK-1R, play critical roles in immune regulation in human and animal models of inflammation. METHODS: We used mature human cord blood mast cells (HCBMC) differentiated from cord blood CD34+ precursor activated with SP in culture. RESULTS: Our data indicate that Substance P strongly activates mature HCBMC in releasing CXCL8 expression and secretion ( CONTROL: 1.200 +/- 1.0; SP: 4.10 +/- 0.90; P < 0.01). Moreover, in a RT-PCR, HCBMC expressed CXCL8 mRNA after Substance P activation. Since calcium ionophore A23187 is a pharmacological activator that raises cytosolic free calcium ion concentraion and stimulates mast cells in the production and secretion of proinflammatory compounds, it was used as positive control. In addition, we found that HCBMCs generate the transcription of histidine decarboxylase (HDC), the enzyme responsible for the generation of histamine from histidine, after SP treatment. Since CXCL8 is a member of the CXC chemokine subfamily with potent chemotactic activity and is a primary inflammatory cytokine we conclude that our results, obtained from HCBMC cultures, a good and valid model in vitro, support the concept that the neurogenic system modulates inflammatory events by Substance P-mediated HCBMC chemokine CXCL8 release. CONCLUSION: The expression, synthesis and release of CXCL8 suggest an increase of inflammatory process in vivo mediated by the recruitment and infiltration of inflammatory cells in inflamed tissues.


Subject(s)
Fetal Blood/cytology , Histidine Decarboxylase/genetics , Interleukin-8/genetics , Mast Cells/drug effects , Substance P/pharmacology , Calcimycin/pharmacology , Cells, Cultured , Dexamethasone/pharmacology , Dose-Response Relationship, Drug , Gene Expression/drug effects , Humans , Mast Cells/metabolism , Mast Cells/ultrastructure , Microscopy, Electron, Transmission , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction
19.
Mult Scler ; 14(6): 739-48, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18505779

ABSTRACT

Free radicals have been found in high concentrations within inflammatory multiple sclerosis (MS) lesions. The superoxide anion (O(2)(-)) reacts rapidly with nitric oxide (NO), producing peroxynitrite (ONOO(-)). Glatiramer acetate (GA) is a specific MS immunomodulator that induces the synthesis of Th2 cytokines, and reduces the frequency of relapses and the formation of active brain lesions. Proinflammatory cytokines could play a role in free radicals production in the peripheral immune system as well as in the central nervous system (CNS). The effect of GA on iNOS, superoxide radicals (O(2)(-)) and 3-nitrotyrosine production by peripheral blood adherent mononuclear cells (PBAMs) was assessed. Our findings demonstrate that in vitro GA reduced spontaneous and LPS-induced iNOS, 3-nitrotyrosine, NO and O(2)(-) production, and that similar inhibition can be demonstrated ex vivo in mononuclear cells obtained from GA-treated patients. The inhibition of the production of free radicals in PBAMs may represent a new therapeutic mechanism against inflammation during MS.


Subject(s)
Free Radicals/metabolism , Immunosuppressive Agents/administration & dosage , Multiple Sclerosis, Relapsing-Remitting/drug therapy , Multiple Sclerosis, Relapsing-Remitting/metabolism , Peptides/administration & dosage , Adult , Cells, Cultured , Female , Glatiramer Acetate , Humans , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/drug effects , Lipopolysaccharides/pharmacology , Male , Middle Aged , Nitric Oxide/blood , Nitric Oxide Synthase Type II/metabolism , Oxidative Stress/drug effects , Superoxides/metabolism , Tyrosine/analogs & derivatives , Tyrosine/metabolism
20.
Int J Immunopathol Pharmacol ; 21(4): 879-89, 2008.
Article in English | MEDLINE | ID: mdl-19144273

ABSTRACT

Erectile dysfunction (ED) is a common medical condition that affects the sexual life of millions of men worldwide. Numerous physical and psychological factors are involved in normal erectile function, including neurological, vascular, hormonal and cavernous functions. The current therapy for the condition is pharmacological and psychotherapeutic which regulates the erectile function and amplifies the NO-mediated response. The aim of this work is to test the action of three common phosphodiesterase inhibitors: Tadalafil, Sildenafil Citrate and Vardenafil at 0.05 microM on human monocytes, analyzing the expression of iNOS protein and mRNA by Western blot and rt-PCR, and production of NO by conversion of L-(2,3,4,5)-[3H]Arginine to L-(3H) citrulline. We also tested the efficiency of the antioxidant network by spectrophotometer (SOD, CAT, GPx and Gr), under normal conditions and after stimulation with LPS. The results showed an increase in ROS levels, similar for all the molecules with regard to the antioxidant enzymes. In all cases the treatment determines a response to the limited efficiency, arriving at a situation in which phosphodiesterase inhibitors + LPS clearly show oxidative stress.


Subject(s)
Cyclic Nucleotide Phosphodiesterases, Type 5/drug effects , Oxidative Stress , Phosphodiesterase Inhibitors/pharmacology , Base Sequence , Blotting, Western , Catalase/metabolism , DNA Primers , Glutathione Peroxidase/metabolism , Glutathione Reductase/metabolism , Humans , Nitric Oxide Synthase Type II/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Superoxide Dismutase/metabolism , Superoxides/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL